What is SOLIRIS?
SOLIRIS (active substance eculizumab) belongs to a class of drugs named monoclonal antibodies. It is introduced to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
How is SOLIRIS supplied?
SOLIRIS is supplied as 300 mg single-use vials containing 30mL of 10 mg/ml for intravenous administration.
In how many countries SOLIRIS is approved for marketing?
SOLIRIS is available/approved in the USA and Europe. We can help you to access it in India.
How can I get SOLIRIS in India?
SOLIRIS is a prescription-only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –email@example.com
We facilitate by-
- Helping in documentation to import the medicine for personal use.
- Finding Genuine and reliable sources in the USA, Europe and Japan.
- Ensuring 100% transparency.
SOLIRIS can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of SOLIRIS (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees.
Can I get SOLIRIS even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country.
The Indian Pharma (IP) can help patients in accessing/importing SOLIRIS, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your enquiry to find-
SOLIRIS in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
How do I contact The Indian Pharma?
- SOLIRIS in the United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
- SOLIRIS in North America – Mexico.
- SOLIRIS in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
- SOLIRIS in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
- SOLIRIS in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
- SOLIRIS in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
- SOLIRIS in Australia and New Zealand.
You can use a different channel to contact The Indian Pharma (TIP) Tele & Mobile: You can reach us on +91 9310090915 or +91-120-4080562.
Email: We can also address your enquiries if sent directly to firstname.lastname@example.org.
We will respond within 24 hours along with eculizumab price & procurement details after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working day after receiving your query form.